The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
872
June 12, 1992
View Complete Issue         Table of Contents 2019 
Pravastatin, Simvastatin, and Lovastatin For Serum Cholesterol Concentrations
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Pravastatin, Simvastatin, and Lovastatin For Serum Cholesterol Concentrations
June 12, 1992 (Issue: 872)
Pravastatin - Bristol-Myers Squibb) and simvastatin (Zocor -Merck), two new inhibitors of cholesterol synthesis similar to lovastatin (Mevacor - Merck), have now been marketed in the USA for treatment of hypercholesterolemia. Lovastatin (Medical...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Pravastatin, Simvastatin, and Lovastatin For Serum Cholesterol Concentrations
Article code: 872a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.